A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer
NCT03425565
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Clear Cell Tumor
Gynecologic Cancer
Advanced Cancer
Interventions
DRUG:
Pembrolizumab
Sponsor
University College, London